Keywords: Prevention of pneumococcal pneumonia

        There is a vaccine available containing 23 antigens ‘85% to 90% belong to this serotype pneumococcal infections caused serious pneumococcal type-specific pneumococcal polysaccharide antigen. Due to the precise level of protection is not known ‘thus not for antibody titer determination ‘but most children over 2 years of age and adults 2 to 3 weeks after inoculation antigen reaction. approximately 50% of vaccinated patients with erythema and / or pain at the injection site; approximately 1% of the people fever ‘myalgia’ or severe local reactions; 5% of people allergic-like or other serious reactions.

        Serious reactions after repeated vaccination is more common in the general idea that large adult vaccination for children over 2 years of age and pneumococcal disease and complications may injection object chronic diseases should also include ‘particularly cardiovascular disease and lung disease; suffering from splenic dysfunction or anatomic asplenia ‘Hodgkin’s disease’ multiple myeloma ‘diabetes’ hiv infection ‘cirrhosis’ alcoholism ‘renal failure’ of organ transplantation and other immune suppression-related diseases patients; children suffering from kidney disease; the elderly ‘especially all respects normal, but has more than 65 years of age, the elderly’ as well as patients with cerebrospinal fluid leakage. immunosuppressed patient antibody response to decline. sickle cell anemia or other causes asplenia children ‘addition to the injection of pneumococcal vaccine’ should also be preventive injection of penicillin. recurrent upper respiratory tract infections (including otitis media and sinusitis) is generally believed not the indication for vaccination protection period is not known ‘but it seems longer .5 years of repeated vaccination; sometimes after 5 to 10 years for high-risk groups’ need to repeat vaccination tend to have a strong local reaction.